Literature DB >> 26337731

Kidney Versus Islet Allograft Survival After Induction of Mixed Chimerism With Combined Donor Bone Marrow Transplantation.

Tetsu Oura1, Dicken S C Ko, Svjetlan Boskovic, John J O'Neil, Vaja Chipashvili, Maria Koulmanda, Kiyohiko Hotta, Kento Kawai, Ognjenka Nadazdin, R Neal Smith, A B Cosimi, Tatsuo Kawai.   

Abstract

We have previously reported successful induction of transient mixed chimerism and long-term acceptance of renal allografts in MHC mismatched nonhuman primates. In this study, we attempted to extend this tolerance induction approach to islet allografts. A total of eight recipients underwent MHC mismatched combined islet and bone marrow (BM) transplantation after induction of diabetes by streptozotocin. Three recipients were treated after a nonmyeloablative conditioning regimen that included low-dose total body and thymic irradiation, horse Atgam (ATG), six doses of anti-CD154 monoclonal antibody (mAb), and a 1-month course of cyclosporine (CyA) (Islet A). In Islet B, anti-CD8 mAb was administered in place of CyA. In Islet C, two recipients were treated with Islet B, but without ATG. The results were compared with previously reported results of eight cynomolgus monkeys that received combined kidney and BM transplantation (Kidney A) following the same conditioning regimen used in Islet A. The majority of kidney/BM recipients achieved long-term renal allograft survival after induction of transient chimerism. However, prolonged islet survival was not achieved in similarly conditioned islet/BM recipients (Islet A), despite induction of comparable levels of chimerism. In order to rule out islet allograft loss due to CyA toxicity, three recipients were treated with anti-CD8 mAb in place of CyA. Although these recipients developed significantly superior mixed chimerism and more prolonged islet allograft survival (61, 103, and 113 days), islet function was lost soon after the disappearance of chimerism. In Islet C recipients, neither prolonged chimerism nor islet survival was observed (30 and 40 days). Significant improvement of mixed chimerism induction and islet allograft survival were achieved with a CyA-free regimen that included anti-CD8 mAb. However, unlike the kidney allograft, islet allograft tolerance was not induced with transient chimerism. Induction of more durable mixed chimerism may be necessary for induction of islet allograft tolerance.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26337731      PMCID: PMC4946954          DOI: 10.3727/096368915X688966

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  25 in total

1.  CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates.

Authors:  Tatsuo Kawai; Hiroshi Sogawa; Svetlan Boskovic; Gregory Abrahamian; Rex-Neal Smith; Siew-Lin Wee; David Andrews; Ognjenka Nadazdin; Ichiro Koyama; Megan Sykes; Henry J Winn; Robert B Colvin; David H Sachs; A Benedict Cosimi
Journal:  Am J Transplant       Date:  2004-09       Impact factor: 8.086

2.  Liver ischemia contributes to early islet failure following intraportal transplantation: benefits of liver ischemic-preconditioning.

Authors:  D Yin; J W Ding; J Shen; L Ma; M Hara; A S Chong
Journal:  Am J Transplant       Date:  2006-01       Impact factor: 8.086

3.  Pathology of an islet transplant 2 years after transplantation: evidence for a nonimmunological loss.

Authors:  R Neal Smith; Sally C Kent; Julie Nagle; Martin Selig; A John Iafrate; Nader Najafian; David A Hafler; Hugh Auchincloss; Tihamer Orban; Enrico Cagliero
Journal:  Transplantation       Date:  2008-07-15       Impact factor: 4.939

4.  HLA-mismatched renal transplantation without maintenance immunosuppression.

Authors:  Tatsuo Kawai; David H Sachs; Megan Sykes; A Benedict Cosimi
Journal:  N Engl J Med       Date:  2013-05-09       Impact factor: 91.245

5.  Overcoming memory T-cell responses for induction of delayed tolerance in nonhuman primates.

Authors:  Y Yamada; S Boskovic; A Aoyama; T Murakami; P Putheti; R N Smith; T Ochiai; O Nadazdin; I Koyama; O Boenisch; N Najafian; M K Bhasin; R B Colvin; J C Madsen; T B Strom; D H Sachs; G Benichou; A B Cosimi; T Kawai
Journal:  Am J Transplant       Date:  2011-11-04       Impact factor: 8.086

6.  Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody.

Authors:  A B Cosimi; F L Delmonico; J K Wright; S L Wee; F I Preffer; L K Jolliffe; R B Colvin
Journal:  Surgery       Date:  1990-08       Impact factor: 3.982

7.  Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance.

Authors:  T Kawai; A Poncelet; D H Sachs; S Mauiyyedi; S Boskovic; S L Wee; D S Ko; A Bartholomew; M Kimikawa; H Z Hong; G Abrahamian; R B Colvin; A B Cosimi
Journal:  Transplantation       Date:  1999-12-15       Impact factor: 4.939

8.  Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes.

Authors:  M D Bellin; F B Barton; A Heitman; J V Harmon; R Kandaswamy; A N Balamurugan; D E R Sutherland; R Alejandro; B J Hering
Journal:  Am J Transplant       Date:  2012-04-11       Impact factor: 8.086

9.  The effect of low versus high dose of streptozotocin in cynomolgus monkeys (Macaca fascilularis).

Authors:  M Koulmanda; A Qipo; S Chebrolu; J O'Neil; H Auchincloss; R N Smith
Journal:  Am J Transplant       Date:  2003-03       Impact factor: 8.086

10.  HLA-mismatched renal transplantation without maintenance immunosuppression.

Authors:  Tatsuo Kawai; A Benedict Cosimi; Thomas R Spitzer; Nina Tolkoff-Rubin; Manikkam Suthanthiran; Susan L Saidman; Juanita Shaffer; Frederic I Preffer; Ruchuang Ding; Vijay Sharma; Jay A Fishman; Bimalangshu Dey; Dicken S C Ko; Martin Hertl; Nelson B Goes; Waichi Wong; Winfred W Williams; Robert B Colvin; Megan Sykes; David H Sachs
Journal:  N Engl J Med       Date:  2008-01-24       Impact factor: 91.245

View more
  12 in total

Review 1.  Preclinical and clinical studies for transplant tolerance via the mixed chimerism approach.

Authors:  Hajime Sasaki; Tetsu Oura; Thomas R Spitzer; Yi-Bin Chen; Joren C Madsen; James Allan; David H Sachs; A B Cosimi; Tatsuo Kawai
Journal:  Hum Immunol       Date:  2017-11-22       Impact factor: 2.850

Review 2.  Translational impact of NIH-funded nonhuman primate research in transplantation.

Authors:  Stuart J Knechtle; Julia M Shaw; Bernhard J Hering; Kristy Kraemer; Joren C Madsen
Journal:  Sci Transl Med       Date:  2019-07-10       Impact factor: 17.956

3.  Transient Mixed Chimerism With Nonmyeloablative Conditioning Does Not Induce Liver Allograft Tolerance in Nonhuman Primates.

Authors:  Sulemon Chaudhry; Yojiro Kato; Joshua Weiner; Paula Alonso-Guallart; Sam Baker; David C Woodland; Jay H Lefkowitch; Raimon Duran-Struuck; Hugo P Sondermeijer; Jonah Zitsman; Mallory L Sears; Anette Wu; Brian Karolewski; Philipp J Houck; Mercedes Martinez; Tomoaki Kato; Megan Sykes; Adam D Griesemer
Journal:  Transplantation       Date:  2020-04-06       Impact factor: 4.939

Review 4.  Transplant research in nonhuman primates to evaluate clinically relevant immune strategies in organ transplantation.

Authors:  Zachary Fitch; Robin Schmitz; Jean Kwun; Bernhard Hering; Joren Madsen; Stuart J Knechtle
Journal:  Transplant Rev (Orlando)       Date:  2019-04-05       Impact factor: 3.943

5.  Immunosuppression With CD40 Costimulatory Blockade Plus Rapamycin for Simultaneous Islet-Kidney Transplantation in Nonhuman Primates.

Authors:  T Oura; K Hotta; J Lei; J Markmann; I Rosales; A Dehnadi; K Kawai; D Ndishabandi; R-N Smith; A B Cosimi; T Kawai
Journal:  Am J Transplant       Date:  2016-09-06       Impact factor: 8.086

Review 6.  A Strategy to Simultaneously Cure Type 1 Diabetes and Diabetic Nephropathy by Transplant of Composite Islet-Kidney Grafts.

Authors:  Thomas Pomposelli; Christian Schuetz; Ping Wang; Kazuhiko Yamada
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-12       Impact factor: 6.055

Review 7.  Mechanisms of Tolerance Induction by Hematopoietic Chimerism: The Immune Perspective.

Authors:  Esma S Yolcu; Haval Shirwan; Nadir Askenasy
Journal:  Stem Cells Transl Med       Date:  2017-01-03       Impact factor: 6.940

8.  Transient-mixed Chimerism With Nonmyeloablative Conditioning Does Not Induce Liver Allograft Tolerance in Nonhuman Primates.

Authors:  Sulemon Chaudhry; Yojiro Kato; Joshua Weiner; Paula Alonso-Guallart; Sam Baker; David C Woodland; Jay H Lefkowitch; Raimon Duran-Struuck; Hugo P Sondermeijer; Jonah Zitsman; Mallory L Sears; Anette Wu; Brian Karolewski; Philipp J Houck; Mercedes Martinez; Tomoaki Kato; Megan Sykes; Adam D Griesemer
Journal:  Transplantation       Date:  2020-08       Impact factor: 5.385

9.  Long-term tolerance of islet allografts in nonhuman primates induced by apoptotic donor leukocytes.

Authors:  Amar Singh; Sabarinathan Ramachandran; Melanie L Graham; Saeed Daneshmandi; David Heller; Wilma Lucia Suarez-Pinzon; Appakalai N Balamurugan; Jeffrey D Ansite; Joshua J Wilhelm; Amy Yang; Ying Zhang; Nagendra P Palani; Juan E Abrahante; Christopher Burlak; Stephen D Miller; Xunrong Luo; Bernhard J Hering
Journal:  Nat Commun       Date:  2019-08-02       Impact factor: 14.919

10.  Integrated whole liver histologic analysis of the allogeneic islet distribution and characteristics in a nonhuman primate model.

Authors:  Geun Soo Kim; Jong Hyun Lee; Du Yeon Shin; Han Sin Lee; Hyojun Park; Kyo Won Lee; Heung-Mo Yang; Sung Joo Kim; Jae Berm Park
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.